Prospective clinical trial on the influence of 1,25(OH)2D3 plasma concentrations on implantation in IVF/ICS-patients

Prospective clinical trial on the influence of 1,25(OH)2D3 plasma concentrations on implantation in IVF/ICS-patients - ENDO_IVF Vitamine D

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014967

Enrollment

100

Registered

2018-06-28

Start date

2018-06-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy rate in IVF/ICSI patients

Interventions

Group 1: In patients with an indication for IVF/ICSI blood is withdraw during the embryo transfer. Blood levels were assessed for calcium, phosphate, 25(OH)D3 and 1,25(OH)2D3 as well as gene expressi

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: - Age between 18 and 45 years (inclusively) - Indication for IVF/ICSI treatment - ability and will to meet study conditions - Informed consent after information

Exclusion criteria

Exclusion criteria: - Known systemic diseases being influenced by vitamine D such as inflammatory diseases or malignic dieseases - Patients declining participation

Design outcomes

Primary

Measure	Time frame
Aim of this monocentric, prospektive study ist to investigate the Influence of 1,25(OH)2D3 plasma concentrations on the implantation in patients with IVF/ICSI treatment	—

Countries

Germany

Contacts

Public ContactMelanie Henes

Department für Frauengesundheit

melanie.henes@med.uni-tuebingen.de07071-29-82211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026